Eli Lilly has been a growth beast in recent years, but its valuation has gotten fairly high along the way.

An exclusive interview with Notre Dame tight end Eli Raridon discussing the 2026 NFL Draft and his experience at this year's East-West Shrine Bowl.

March 2 (Reuters) - Eli Lilly CFO Lucas Montarce said on Monday it is preparing to launch its new oral obesity drug, orforglipron, in the United States as early as the second quarter of this year, ...

Feb 26 (Reuters) - Eli Lilly's experimental weight-loss pill, orforglipron, caused more side effects and treatment ...

Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be available this spring.

As reported by the Charlotte Business Journal, the filing is valued at roughly $77 million and is tied to work inside an existing Lilly facility described as a new manufacturing line for injectable ...

Eli Lilly's full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and profit ...

Eli Lilly's decision to reduce the price of its popular weight loss drug makes more sense than it appears at first. The company still has a robust business that is delivering excellent results and ...

The legendary quarterback, who is a two-time Super Bowl MVP, was snubbed from the pro football honor once more ...

Eli isn’t just an unapologetic pop stan—she’s got some majorly famous fans of her own in Olivia Rodrigo and SZA.